The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary operation in synchroneous metastasized invasive breast cancer patients: first oncologic outcomes of the prospective randomized phase III ABCSG 28 POSYTIVE trial.
 
Florian Fitzal
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Myriad Genetics; NanoString Technologies
Travel, Accommodations, Expenses - Roche
 
Marija Balic
No Relationships to Disclose
 
Vesna Bjelic-Radisic
No Relationships to Disclose
 
Michael Hubalek
No Relationships to Disclose
 
Christian F. Singer
No Relationships to Disclose
 
Guenther G. Steger
Honoraria - Amgen; Cephalon; Pfizer; Roche; Teva
Research Funding - Eisai; Roche; Teva
Travel, Accommodations, Expenses - Acraf; Novartis; Roche
 
Christian Marth
No Relationships to Disclose
 
Peter Schrenk
No Relationships to Disclose
 
Michael Knauer
No Relationships to Disclose
 
Anton Haid
No Relationships to Disclose
 
Viktor Wette
No Relationships to Disclose
 
Irmgard Luisser
Travel, Accommodations, Expenses - Roche
 
Richard Greil
No Relationships to Disclose
 
Reinhold Fuegger
No Relationships to Disclose
 
Ursula Swoboda
No Relationships to Disclose
 
Lidija Soelkner
No Relationships to Disclose
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Celgene; GlaxoSmithKline; Novartis; OBI Pharma; Roche
Consulting or Advisory Role - Accelsiors; AstraZeneca; Novartis
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Novartis; Roche
Research Funding - AstraZeneca; Novartis; Pfizer; Roche